The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2025
Filed:
Dec. 03, 2020
Applicants:
Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, CN;
Ascentage Pharma Group Corp Limited, Hong Kong, CN;
Inventors:
Assignees:
ASCENTAGE PHARMA (SUZHOU) CO., LTD., Jiangsu, CN;
ASCENTAGE PHARMA GROUP CORP LIMITED, Hong Kong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/635 (2006.01); A61K 31/454 (2006.01); A61K 31/4745 (2006.01); A61K 31/519 (2006.01); A61K 31/55 (2006.01); A61K 31/573 (2006.01); A61K 31/706 (2006.01); A61K 39/395 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/635 (2013.01); A61K 31/454 (2013.01); A61K 31/4745 (2013.01); A61K 31/519 (2013.01); A61K 31/55 (2013.01); A61K 31/573 (2013.01); A61K 31/706 (2013.01); A61K 39/3955 (2013.01); A61P 35/02 (2018.01);
Abstract
Described herein are methods of treating a hematologic malignancy in a patient in need thereof, comprising administering to the patient a Bcl-2 inhibitor in a step-wise dosing regimen.